查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1678773

全球傷口護理管理設備市場 - 2025 年至 2033 年

Global Wound Care Management Devices Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 220 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球傷口護理管理設備市場規模達到 206.9 億美元，預計到 2033 年將達到 290 億美元，在 2025-2033 年預測期內的複合年成長率為 3.8%。

傷口護理管理設備是用於治療、癒合和預防各種類型傷口（包括急性、慢性和手術傷口）的醫療工具。它們透過促進更快癒合、降低感染風險和減少併發症來改善患者的治療效果。市場包括 NPT 系統、保濕敷料、生物工程產品和手術設備等先進解決方案。隨著慢性病發病率的上升、人口老化以及隨之而來的外科手術的增加，對創新傷口護理管理設備的需求日益成長。

市場動態：

促進因素與約束因素

慢性傷口發生率不斷上升

由於糖尿病足潰瘍、壓瘡和靜脈性腿部潰瘍等慢性傷口的發生率不斷增加，傷口護理管理設備市場正在蓬勃發展。人口老化、糖尿病盛行率上升以及肥胖等因素導致難以癒合的傷口的發生率不斷增加。需要先進的解決方案來有效治療和預防併發症。這種需求，尤其是在北美和歐洲等已開發地區，正在推動對創新設備的需求。

例如，在 5 年的時間裡，患有傷口的醫療保險受益人從 820 萬增加到 1,050 萬，傷口盛行率增加了 13%。 65歲以下民眾增幅最大。變化最大的是動脈潰瘍、皮膚病和外傷。無論採用哪種方法，支出都有所減少，採用最保守的方法，支出減少了 297 億美元至 225 億美元。

高級傷口護理產品成本高昂

負壓傷口治療系統和生物工程敷料等先進傷口護理產品和療法的成本高昂，阻礙了市場成長，尤其是在中低收入地區。有限的報銷政策和傳統的傷口護理產品也限制了它們的採用，導致醫療保健提供者和患者選擇傳統的選擇。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動態

  • 影響因素
    • 驅動程式
      • 慢性傷口盛行率不斷上升
    • 限制
      • 高級傷口護理產品成本高昂
    • 機會
    • 影響分析

第5章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 6 章：依產品類型

  • 先進的傷口護理設備
  • 手術傷口護理設備
  • 傳統傷口護理設備

第 7 章：按傷口類型

  • 慢性傷口
  • 急性傷口

第 8 章：按最終用戶

  • 醫院和診所
  • 家庭醫療保健
  • 長期照護機構

第9章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 併購分析

第 11 章：公司簡介

  • Smith & Nephew plc
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 主要進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • 3M Company
  • Cardinal Health, Inc.
  • Medtronic plc
  • Coloplast A/S
  • ConvaTec Group plc
  • Johnson & Johnson Services, Inc.
  • Molnlycke Health Care AB
  • Hollister Incorporated
  • Medline Industries, Inc
  • Similar data will be provided for each market player.
  • MiMedx 集團公司
    • 管道產品描述
    • 產品關鍵績效指標 (KPI)
    • 主要活動
    • 市場進入時間表
    • 產品滲透率
    • 銷售估計和預測
  • 泰利Group Limited
  • DeRoyal 工業公司
  • 將為每個市場參與者提供類似的資料。

第 12 章：附錄

簡介目錄
Product Code: MD208

The Global wound care management devices market reached US$ 20.69 billion in 2024 and is expected to reach US$ 29.00 billion by 2033, growing at a CAGR of 3.8% during the forecast period 2025-2033.

Wound care management devices are medical tools designed to treat, heal, and prevent various types of wounds, including acute, chronic, and surgical ones. They improve patient outcomes by promoting faster healing, reducing infection risks, and minimizing complications. The market includes advanced solutions like NPT systems, moisture-retentive dressings, bioengineered products, and surgical devices. With the rising incidence of chronic diseases, aging populations, and the subsequent increase in surgical procedures, the demand for innovative wound care management devices is growing.

Market Dynamics: Drivers & Restraints

Increasing Incidence of Chronic Wounds

The market for wound care management devices is booming due to the increasing incidence of chronic wounds like diabetic foot ulcers, pressure ulcers, and venous leg ulcers. Factors like an aging population, rising prevalence of diabetes, and obesity contribute to the increasing incidence of non-healing wounds. Advanced solutions are needed for effective healing and preventing complications. This demand, especially in developed regions like North America and Europe, is driving the demand for innovative devices.

For instance, over a 5-year period, Medicare beneficiaries with wounds increased from 8.2 million to 10.5 million, with a 13% increase in wound prevalence. The largest increase was seen in those aged <65 years. The largest changes were in arterial ulcers, skin disorders, and traumatic wounds. Expenditures decreased regardless of the three methods used, with a reduction of $29.7 billion to $22.5 billion for the most conservative method.

High Cost of Advanced Wound Care Products

The high cost of advanced wound care products and therapies, such as negative pressure wound therapy systems and bioengineered dressings, hinders market growth, especially in low and middle-income regions. Limited reimbursement policies and traditional wound care products also limit their adoption, leading healthcare providers and patients to opt for traditional options.

Segment Analysis

The global wound care management devices market is segmented based on product type, wound type, end user and region.

Product Type:

The advanced wound care devices in the product type segment are expected to dominate with the highest market share.

The advanced wound care devices segment holds a major portion of the wound care management devices market share and is expected to continue to hold a significant portion during the forecast period.

Advanced wound care devices, such as negative pressure wound therapy systems, advanced dressings, and bioactive products, are crucial for treating complex and chronic wounds like diabetic foot ulcers, pressure ulcers, and surgical wounds. They facilitate faster healing, reduce infection risks, and minimize patient discomfort. Demand for these devices is growing in North America and Europe due to their effectiveness in promoting wound healing, especially for patients with underlying conditions like diabetes and cardiovascular diseases. As the demand rises, manufacturers are actively involved in the launch of advanced products.

For instance, in February 2025, Biomiq Inc., a leading Canadian provider of advanced wound care solutions, introduced PureGel, a super-oxidizing nano-hydrogel. This Class II medical device offers a long-lasting, non-cytotoxic solution for wound management, marking a new era in advanced wound care.

Geographical Analysis

North America is expected to hold a significant position in the wound care management devices market share.

North America holds a substantial position in the wound care management devices market and is expected to hold most of the market share in the future. This dominance is fuelled by the increasing prevalence of chronic wounds like diabetic foot ulcers, pressure ulcers, and venous leg ulcers. The region's high diabetes and obesity rates necessitate advanced wound care solutions. The presence of established healthcare infrastructure, increasing healthcare expenditure, and advanced wound care technologies drive market growth.

For instance, in May 2024, AVITA Medical, a regenerative medicine company, received FDA approval for its premarket approval supplement for the RECELL GO System, a next-generation autologous cell harvesting device that uses a patient's own skin's regenerative properties to treat thermal burn wounds and full-thickness skin defects.

Competitive Landscape

The major global players in the wound care management devices market include Smith & Nephew plc, 3M Company, Cardinal Health, Inc., Medtronic plc, Coloplast A/S, ConvaTec Group plc, Johnson & Johnson Services, Inc., Molnlycke Health Care AB, Hollister Incorporated, Medline Industries, Inc., and among others.

Key Developments

  • In September 2024, Solventum launched the V.A.C. Peel and Place Dressing, an integrated dressing and drape that can be applied in less than two minutes and worn by patients for up to seven days. Traditional dressings for negative pressure wound therapy take longer, require a multi-step process, and may need to be changed three times a week.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Wound Care Management Devices market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 220 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Product Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Wound Type
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Prevalence of Chronic Wounds
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of Advanced Wound Care Products
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Forces Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index by Product Type
  • 6.2. Advanced Wound Care Devices*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Surgical Wound Care Devices
  • 6.4. Traditional Wound Care Devices

7. By Wound Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 7.1.2. Market Attractiveness Index by Wound Type
  • 7.2. Chronic Wounds*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Acute Wounds

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals and Clinics*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Home Healthcare
  • 8.4. Long-term Care Facilities

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. Smith & Nephew plc*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. 3M Company
  • 11.3. Cardinal Health, Inc.
  • 11.4. Medtronic plc
  • 11.5. Coloplast A/S
  • 11.6. ConvaTec Group plc
  • 11.7. Johnson & Johnson Services, Inc.
  • 11.8. Molnlycke Health Care AB
  • 11.9. Hollister Incorporated
  • 11.10. Medline Industries, Inc
  • Similar data will be provided for each market player.

Emerging Market Players

  • 11.11. MiMedx Group, Inc*
    • 11.11.1. Pipeline Products Description
    • 11.11.2. Product Key Performance Indicators (KPIs)
    • 11.11.3. Key Activities
    • 11.11.4. Market Entry Timelines
    • 11.11.5. Product Penetration Rate
    • 11.11.6. Sales Estimation and Projections
  • 11.12. Talley Group Ltd
  • 11.13. DeRoyal Industries, Inc.
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us